In an age of increasingly personalized healthcare, Elizabeth Philp has become a formidable figure of innovation, especially in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a movement to make tailor-made medications more available, questioning the standard one-size